AMZN vs LFMD
AMZN: A dominant global e-commerce and cloud infrastructure platform driving retail, digital entertainment, and enterprise technology services. LFMD: LifeMD is a vertically integrated, subscription-based telehealth platform that combines virtual medical care with internal pharmacy fulfillment to provide accessible, longitudinal patient care.
Side-by-side fundamentals
| Metric | AMZN | LFMD | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $254.06 | $2.65 | |
| Market cap | $2.74T | $128M | |
| P/E as of 2026-10-08 | 20.44 | 311.76 | AMZN lower |
| Net margin FY2025, SEC XBRL | +10.8% | +7.4% | AMZN higher |
| Gross margin FY2025, SEC XBRL | n/a | +85.7% | |
| Operating margin FY2025, SEC XBRL | +11.2% | -4.0% | AMZN higher |
| ROE FY2025, SEC XBRL | +18.9% | +62.0% | LFMD higher |
| ROA FY2025, SEC XBRL | +9.5% | +20.4% | LFMD higher |
| Debt / equity as of 2026-09-03 | 0.28 | 0.00 | LFMD lower |
| Revenue growth (YoY) as of 2026-09-03 | +15.8% | -16.7% | AMZN higher |
| Revenue CAGR (3y) SEC XBRL | +11.7% | +17.7% | LFMD higher |
| Dividend yield as of 2026-09-03 | n/a | +1.9% | |
| Beta as of 2026-09-03 | 1.36 | 1.64 | |
| 1-year return as of 2026-10-08 close | +12.8% | -60.1% | AMZN higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.